Thermo Fisher announces series of actions in proteomics

Nov. 29, 2021

Thermo Fisher Scientific has launched a series of solutions and co-marketing agreements in proteomics.

Specifically, Thermo Fisher:

  • Extended its co-marketing agreement with Biognosys, a developer of solutions for plasma analysis. The PQ500 Reference Peptide Kit from Biognosys quantifies more than 500 proteins in human plasma/serum samples as part of the SureQuant IS-PRM workflow, enabled with the Thermo Scientific Orbitrap Exploris 480 mass spectrometer.
  • Launched the Thermo Scientific Vanquish Neo Ultra-High Performance Liquid Chromatography (UHPLC) System. The new system is designed for high-sensitivity LC-MS applications.
  • Acquired Belgium-based PharmaFluidics, the developer of the μPAC range of micro-chip-based chromatography columns. The µPAC portfolio of columns enhance LC performance in biomarker, proteomics and drug research and development applications.
  • Signed a co-marketing agreement with Cellenion for a sample preparation solution, cellenONE, that combines single-cell isolation and nanoliter dispensing to perform every step of sample preparation using a single device.

Visit Thermo Fisher for more news